Back to Atlas
CTransientNootropic/stimulant caution
CMP-0447
Supplement/research
Sarcosine
Glutamatergic / Nootropic
Cognition and negative-symptom support positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Amino acid derivative
- Primary mechanism
- GlyT1 inhibition / NMDA co-agonist support
- Primary market use
- Cognition/psychiatry
Pharmacology
- Molecular weight (Da)
- 89.1
- Oral bioavailability
- High
- Half-life
- ~1-3 h
- Route tags
- Oral
- Evidence level
- Human/research
- Clinical status
- Supplement/research
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
EveryChem-style nootropic class